Testing a new drug for food allergies
Part of Immune system & allergy clinical trials.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 55 years old.
- You have a confirmed allergy to peanut, milk, egg, cashew, or walnut, based on skin tests, blood tests, and a supervised food challenge.
- Your total IgE level and body weight must be suitable for the study drug dose.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You do not have uncontrolled asthma, severe medical conditions, or recent use of certain medications like steroids or beta-blockers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new formula designed for children diagnosed with cow's milk allergy. It evaluates whether the formula is safe and well-tolerated.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This study looks for blood test patterns that may predict whether a child with eczema (atopic dermatitis) is likely to have a food allergy. If you join, you may do supervised oral food challenges with a placebo and the suspected foods to see what triggers symptoms.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This study is observing children with food allergies who are willing to do an oral food challenge (eating the allergen in a safe clinic setting). It helps doctors learn more about how allergies affect children.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
Hear when a new Ig-E Mediated Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.